UPDATED Mar 18, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
FDE | €35.75 | -11.5% | -5.5% | €187.0m | €68.07 | PE15.6x | E25.8% | n/a | Energy | ||
OSE | €4.86 | -5.6% | -5.6% | €104.8m | €7.15 | PS29x | E81.1% | n/a | Pharmaceuticals & Biotech | ||
ALAIR | €4.92 | -0.8% | -3.5% | €29.8m | €7.60 | PE26x | E44.5% | n/a | Consumer Durables | ||
ALDVI | €1.44 | -3.9% | -65.2% | €17.7m | €6.90 | PS6.5x | E101.7% | n/a | Pharmaceuticals & Biotech | ||
AL2SI | €3.83 | -18.2% | 69.5% | €72.8m | €7.80 | PB2.6x | E108.2% | n/a | Tech | ||
ALOKW | €20.00 | -0.5% | 2.4% | €165.2m | €30.30 | PE28.1x | E43.0% | n/a | Capital Goods | ||
ALBIZ | €6.28 | -1.9% | -3.4% | €36.6m | €11.50 | PE304.4x | E70.3% | n/a | Media | ||
ALECO | €3.25 | -3.0% | -50.0% | €10.9m | €4.50 | PB2.2x | E103.5% | n/a | Consumer Retailing | ||
MLLCB | €3.76 | 1.1% | -14.5% | €16.1m | €4.40 | PE32.2x | E55.4% | n/a | Real Estate Management and Development | ||
ALESE | €4.75 | -30.8% | -42.6% | €69.1m | €11.70 | PS1.7x | E119.9% | n/a | Capital Goods | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | Pharmaceuticals & Biotech | ||
ADOC | €9.38 | 0.9% | 216.4% | €132.1m | €9.70 | PS12.2x | E84.1% | n/a | Pharmaceuticals & Biotech | ||
ALLEC | €8.05 | -1.2% | 14.7% | €68.4m | €9.00 | PS1.1x | E86.1% | 0% | Tech | ||
ALAGP | €1.12 | 0% | -84.6% | €4.0m | €2.30 | PB0.3x | E103.8% | 0% | Capital Goods | ||
ALCUR | €3.57 | -8.2% | 55.2% | €20.4m | €5.45 | PS1.1x | E87.7% | n/a | Capital Goods | ||
AELIS | €13.35 | 0% | -5.6% | €175.3m | €21.33 | PS17.9x | E29.2% | n/a | Pharmaceuticals & Biotech | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | Pharmaceuticals & Biotech | ||
ALPCV | €2.26 | -10.3% | 13.0% | €10.2m | €3.70 | PE44.8x | E81.2% | n/a | Capital Goods | ||
ALCAP | €5.86 | 4.6% | -44.5% | €12.8m | €9.50 | PB0.2x | E112.1% | 0% | Real Estate Management and Development | ||
POXEL | €0.51 | 15.9% | -27.6% | €19.8m | €3.50 | PS12.8x | E22.1% | n/a | Pharmaceuticals & Biotech | ||
MEDCL | €9.44 | -2.2% | 11.1% | €271.4m | €15.48 | PS19.2x | E65.9% | n/a | Pharmaceuticals & Biotech | ||
ALCOR | €35.10 | 0% | 150.7% | €154.5m | €35.00 | PS12.1x | E136.3% | n/a | Healthcare | ||
ALCJ | €3.27 | -4.0% | -28.2% | €124.2m | €7.10 | PS17.3x | E92.4% | n/a | Healthcare | ||
GNFT | €3.17 | -1.2% | -16.8% | €157.6m | €9.38 | PS5.4x | E52.3% | n/a | Pharmaceuticals & Biotech |